Latest
Transplant related melanoma may hold the key to the sentinel node
Melanoma is one of the most often reported and lethal donor derived malignancies but nature's own unfortunate experiment may hold the answer to mysterious behaviour in the sentinel node.
Featured Article
Staistical errors continue to hamper progress in the MSLT-1 trial looking at the potential role of sentinel node biopsy in the treatment of malignant melanoma.
Melanoma in the News
- Doctor, doctor: Popping pills, plus moles and melanoma - The Guardian
- How Sir Bobby's legacy lives on in cancer charity - Journal Live
- Government urged to cut VAT on sun cream amid skin cancer fears - The Guardian
- The evolution of melanoma diagnosis: 25 years beyond the ABCDs - Science Centric
- Darker skin doesn't mean melanoma immunity - Reuters
- MoneyTV with Donald Baillargeon, 7/30 - MarketWatch (press release)
- WAIMR to fund two new melanoma projects - Australian Life Scientist
- Critic's notebook: TV news from Showtime - Salt Lake Tribune
- Tanning Salons: More Heat? - Wall Street Journal
- 'cancer plaster' firm raises cash - BBC News
Recent Articles
Links We Like
Categories
Proudly Supporting
Recently Published
- Some of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification Is Not Evidence Based.
- False-positivity in the sentinel lymph nodes in melanoma and breast cancer.
- Does the two-week rule pathway improve the diagnosis of soft tissue sarcoma? A retrospective review of referral patterns and outcomes over five years in a regional sarcoma centre.
- Transmission of donor melanoma by organ transplantation.
- The surgical management of soft tissue tumours arising in the abdominal wall.
- Surgical management of primary retroperitoneal sarcoma.
- Synchronous mantle cell lymphoma, chronic lymphocytic leukaemia and melanoma in a single lymph node.
- Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma.
- Prognostic false-positivity and cost-effectiveness in sentinel node biopsy in melanoma.
- Clinical outcomes of extra-thoracic solitary fibrous tumours.